Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
N/A
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
200-559-2/63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
N/A
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
N/A
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
236-675-
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2013-07-31
Product name
KETOROLAC TROMETHAMINE TABLETS
Chemical name
(±)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound
Manufacturer Name
TEVA
Emergency telephone
1-800/424-9300, 01-703-527-3887
Icons in SDS
Company Information
company name
TEVA
e-mail address of the competent person responsible for the Safety Data Sheet
TevaSDSRequest@tevapharm.com
Section 2
SECTION 2: Hazards identification
Product definition
This product consists of odorless, white tablets which are round
Health hazards
In the workplace, dusts from damaged tablets may cause irritation of contaminated skin or eye Inhalation of dusts may be harmful. Non-therapeutic ingestion may be harmful. Ingestion of large amount may be fatal due to serious gastrointestinal and/or cardiovascular system effects. In therapeutic use, the most common adverse effects reported are upset stomach and other gastric upset. Therapeutic use of Ketorolac Tromethamine can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. As a NSAID, therapeutic use of Ketorolac Tromethamine may cause an increased risk of serious cardiovascular thrombotic events, sometimes fatal. This risk may increase with duration of use. Severe anaphylactic reactions can occur in persons allergic to NSAIDs. As a NSAID, may cause harm to the fetus during pregnancy. Limited evidence of mutagenic effect, based on animal information. These effects may be possible as a result of workplace exposure. Refer to Section 11 (Toxicological Information) for additional information on adverse effects. Flammability Hazards: This product is combustible and can ignite if highly heated or if exposed to direct flame. When involved in a fire, this product may decompose and produce irritating vapors and toxic compounds (including carbon, magnesium, titanium, and nitrogen oxides). Reactivity Hazards: This product is not reactive.
Environmental hazards
The active ingredient is toxic to aquatic organism and can cause long-term harm to aquatic organisms if accidentally released. All environmental release should be avoided. Emergency Recommendations: Emergency responders must wear personal protective equipment suitable for the situation to which they are responding.